On Thursday, Aurobindo Pharma informed that it has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Acetaminophen injection, 1,000 mg/ 100 ml single-dose vial (SDV), which is a generic equivalent of Mallinckrodt’s Ofirmev injection.